Description

Imbruvica is a medication used primarily to treat certain types of blood cancers, including chronic lymphocytic leukemia (CLL) and mantle cell lymphoma (MCL). It works by inhibiting a specific protein that is crucial for the survival and proliferation of cancer cells.

Interpreter Notes

Interpreters should be aware that 'Imbruvica' may be referred to by its generic name, ibrutinib, in some contexts. It is important to maintain a formal tone and avoid colloquial terms when discussing this medication. Ensure clarity when translating dosage and administration instructions, as these can vary significantly.

Example Sentences

EN: The doctor prescribed Imbruvica to manage the patient's chronic lymphocytic leukemia.

ES: El médico recetó Imbruvica para manejar la leucemia linfocítica crónica del paciente.

Common Interpreter Mistakes

Confusing Imbruvica with similar-sounding medications; misinterpreting the context of use as it relates to other cancer treatments; failing to clarify the distinction between brand and generic names.